This site is intended for healthcare professionals

Adverum Biotechnologies provides update on the INFINITY trial evaluating ADVM 022 in patients with diabetic macular edema.

Read time: 1 mins
Last updated:3rd May 2021
Published:3rd May 2021
Condition: Diabetic Macular Oedema
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest